Blending the art of food and cooking with the science of medicine, this new NASPGHAN webinar series brings you live interactive educational webinars that highlight the importance of food and diet within a patient’s health plan, and how to use culinary medicine tailored to specific GI diseases and symptoms.

Eosinophilic Esophagitis, which will highlight elimination diets and discuss the adequacy of these diets in pediatrics and their application in pediatric GI diseases.  The webinar will pair a physician and a registered dietitian, and will include a brief overview of the GI condition, an introduction of dietary management recommendations and a recorded demonstration on how to carry out the recommendations using corresponding recipes (conducted by a home chef).

Joint NASPGHAN PASPGHAN Webinar -  Celiac Disease: Current Guidelines and Practice Realities on Both Sides of the Atlantic.  

DEBATE ON DIAGNOSTIC STRATEGIES: TO BIOPSY OR NOT TO BIOPSY?

WHAT TO DO WITH DIFFICULT CELIAC CASES: PRACTICE MANAGEMENT AND PATIENT FOLLOW-UP

Blending the art of food and cooking with the science of medicine, this new NASPGHAN webinar series brings you live interactive educational webinars that highlight the importance of food and diet within a patient’s health plan, and how to use culinary medicine tailored to specific GI diseases and symptoms.

Wellness and Prevention will highlight plant-based and Mediterranean diets and discuss the adequacy of these diets in pediatrics and their application in pediatric GI diseases.  The webinar will pair a physician and a registered dietitian, and will include a brief overview of the GI condition, an introduction of dietary management recommendations and a recorded demonstration on how to carry out the recommendations using corresponding recipes (conducted by a home chef).

Supported by an educational grant from Kate Farms.

Joint NASPGHAN PASPGHAN Webinar -  Celiac Disease: Current Guidelines and Practice Realities on Both Sides of the Atlantic.  

DEBATE ON DIAGNOSTIC STRATEGIES: TO BIOPSY OR NOT TO BIOPSY?

WHAT TO DO WITH DIFFICULT CELIAC CASES: PRACTICE MANAGEMENT AND PATIENT FOLLOW-UP

Endoscopic procedures in pediatric patients can result in a unique set of challenges and complications. This webinar will bring in-depth knowledge and practical strategies for preventing, identifying and managing key complications such as perforation, bleeding and post-polypectomy issues, along with expert guidance on managing stricture dilation in young patients. Don’t miss this opportunity to advance your expertise in the dynamic and delicate field of pediatric gastrointestinal care.

The last two years have seen rapid advancement in therapy options for EoE, moving beyond dietary elimination, off-label use of proton pump inhibitors and swallowed topical steroids. In May of 2022, dupilumab became the first FDA approved medication for EoE in patients 12 years and older, and January 2024 brought approval for ages 1-11. Next came the first and only oral medication approved for EoE - budesonide oral suspension EOHILIA. These changes have resulted in questions around best approaches and practices in treating EoE patients. Our webinar will deliver a particular focus on new medication options for pediatric patients with EoE as well as challenges faced by clinicians and patients.

The last two years have seen rapid advancement in therapy options for EoE, moving beyond dietary elimination, off-label use of proton pump inhibitors and swallowed topical steroids. In May of 2022, dupilumab became the first FDA approved medication for EoE in patients 12 years and older, and January 2024 brought approval for ages 1-11. Next came the first and only oral medication approved for EoE - budesonide oral suspension EOHILIA. These changes have resulted in questions around best approaches and practices in treating EoE patients. Our webinar will deliver a particular focus on new medication options for pediatric patients with EoE as well as challenges faced by clinicians and patients.

Pediatric dysphagia, or difficulty swallowing, affects children ages 3 to 17 in the United States.  While there are four phases of the physiologic swallow, clinicians frequently evaluate and manage symptoms associated with the oropharyngeal and esophageal phases.  

There are numerous possible diagnoses that may contribute to dysphagia and its sequelae, and therefore effectively navigating the investigative process can be challenging.

The development of new diagnostic techniques have shown to be beneficial in recognizing underlying pathophysiology, in addition to identifying new diagnoses.

Current Concepts in Pediatric Dysphagia: Oropharyngeal, Esophageal and the Extremes aims to provide a detailed discussion on the novel diagnostic techniques and therapeutic management of these disorders, including supragastric belching and retrograde cricopharyngeal dysfunction.

Pediatric dysphagia, or difficulty swallowing, affects children ages 3 to 17 in the United States.  While there are four phases of the physiologic swallow, clinicians frequently evaluate and manage symptoms associated with the oropharyngeal and esophageal phases.  

There are numerous possible diagnoses that may contribute to dysphagia and its sequelae, and therefore effectively navigating the investigative process can be challenging.

The development of new diagnostic techniques have shown to be beneficial in recognizing underlying pathophysiology, in addition to identifying new diagnoses.

Current Concepts in Pediatric Dysphagia: Oropharyngeal, Esophageal and the Extremes aims to provide a detailed discussion on the novel diagnostic techniques and therapeutic management of these disorders, including supragastric belching and retrograde cricopharyngeal dysfunction.

Systematic Review of Family and Pediatric Constipation: An Overlooked Piece of the Puzzle August 2024 JPGN